ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Creative Diagnostics Launches Comprehensive Solutions for Antiviral Testing with Diverse Animal Models

Creative Diagnostics Launches Comprehensive Solutions for Antiviral Testing with Diverse Animal Models
Creative Diagnostics announces its comprehensive portfolio of Animal Models for Antiviral Testing.

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics announces its comprehensive portfolio of Animal Models for Antiviral Testing. This suite of services offers researchers a vital tool in the fight against viruses, accelerating the development of new vaccines and antiviral therapies.

Viruses are notorious for their ability to instigate widespread health crises that seriously affect human health. They can cause a wide range of diseases, including hemorrhagic, gastrointestinal, pharyngeal and neuroinvasive infections. To effectively combat these diseases, it is critical to understand the biology of these viruses and how they establish infection and induce pathogenesis in the human host.

The study of virulent strains requires the selection of appropriate in vivo systems that accurately reflect the course of human disease. Animal models have been used for centuries to study viral infections, allowing researchers to monitor and control disease progression, evaluate vaccine efficacy, and develop drugs and therapies. Animal models play a critical role in advancing our understanding of viral mechanisms and improving our ability to combat viral infections.

Creative Diagnostics now offers a comprehensive suite of animal models specifically designed for antiviral evaluation. These animal model procedures for antiviral testing include selection of viral strains and inoculum, animal preparation and handling, clinical observation, pathology, histology and other examinations, and data analysis. These models are invaluable tools for the development of novel antiviral therapies and for evaluating the efficacy, safety and pharmacokinetics of potential antiviral compounds in a controlled environment prior to human clinical trials.

Creative Diagnostics can develop customized animal models, provide access to a variety of species and routes of inoculation, conduct thorough evaluations of drug candidates, and deliver clear, timely results with complete reporting. In addition, Creative Diagnostics offers a wide range of laboratory animals (e.g. rhesus monkeys, mice, rabbits, guinea pigs, cotton rats, ducks) for the convenience of its clients. All animals are kept in clean, spacious, well-fed environments to prevent stress and abnormal behavior. These models provide a multifaceted view of the dynamics of infection, including a range of parameters such as clinical signs, viral proliferation rates, clinicopathologic features, and cellular and humoral immune responses.

With years of experience in development of animal models for antiviral testing, Creative Diagnostics ensures that a single scientific study for each project is supported by a precise design that promotes groundbreaking discoveries in viral pathogenesis and therapy. The company also provides a full range of pharmacokinetics/pharmacodynamics (PK/PD) services and toxicology services.

Creative Diagnostics is committed to providing quality services that are both cost-effective and unparalleled, while adhering to the strictest ethical principles of animal care and welfare to ensure that its practices meet the highest standards of humane and responsible science. For more information on how these animal models can expedite your development of new antiviral therapies, please visit https://antiviral.creative-diagnostics.com/animal-models-for-antiviral-testing.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.

Media Contact
Company Name: Creative Diagnostics
Contact Person: Thomas Schmitt
Email: Send Email
State: New York
Country: United States
Website: https://antiviral.creative-diagnostics.com/


Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.